Medgend Icon

Ledgend of Medicine







discontinued


Thalomid

Not all medicines are safe to take when you are pregnant. Some medicines can harm your baby. That includes over-the-counter or prescription drugs, herbs, and supplements.

Always speak with your health care provider before you start or stop any medicine. Not using medicine that you need may be more harmful to you and your baby than using the medicine. For example, many pregnant women take prescription medicines for health problems like diabetes, asthma, seizures, and heartburn. The decision about whether or not to take a medicine depends on the risks and benefits. You and your health care provider should make this choice together.

Pregnant women should not take regular vitamins. They may have too much or too little of the vitamins that you need. There are special vitamins for pregnant women. It is important to take 0.4 mg of folic acid every day before you become pregnant through the first part of your pregnancy. Folic acid helps to prevent birth defects of the baby's brain or spine.

Food and Drug Administration

Thalomid FDA Approved Drugs

THALOMID [ThalidomideC13H10N2O4]
RX
-
100mg (oral capsule)
150mg (oral capsule)
200mg (oral capsule)
CelgeneJan 17, 2003
  • Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl).
  • Approval for marketing only under a special restriction program approved by fda called 'system for thalidomide education and prescribing safety' (s.t.e.p.s.).
  • Maintenance therapy for prevention and supression of the cutaneous manifestations of enl recurrence.
  • Method for delivering a drug to a patient in need of the drug, while avoiding the occurence of an adverse side effect known or suspected of being caused by said drug.
  • Treatment of cutaneous manifestations of erythema nodosum leprosum (enl) in connection with a special program approved by fda called 'system for thalidomide education and prescribing safety' (s.t.e.p.s.).
  • Treatment of male patient having a disease or condition responsive to a teratogenic drug.
  • Use in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.
  • Use of thalidomide in combination with dexamethasone for the treatment of patients with newly diagnosed multiple myeloma.
  • Use of thalidomide in treatment of cutaneous manifestations of erythema nodosum leprosum (enl).
  • Use of thalidomide while preventing the exposure of a fetus or other contraindicated individual to thalidomide.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.